FDA Approved: IRBESARTAN — Original Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved Amneal's original application for irbesartan (IRBESARTAN), enabling a generic version of the antihypertensive medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy in Type 2 Diabetes with Proteinuria
• Hypertension

Drugs mentioned

• Irbesartan (irbesartan)

Snippet

ORIG AP for IRBESARTAN (IRBESARTAN)